Evaluation of the ability of MCTR3, PCTR3, 17R-RvD3, and RvD2 to regulate phagocyte responses based on disease severity (ie, WHO ordinal scale), demonstrated a trend towards upregulation of CD162 on neutrophils from patients with COVID-19 with milder disease. The gene discussed is SELPLG; the disease is COVID-19.